MAD2L1 and colorectal carcinoma: For MAD2L1 84Leu/Met SNP, heterozygous or homozygous variant genotypes significantly increased the CRC risk compared with the homozygous wild type in dominant genetic models, with OR equal to 1.48 (95% CI: 1.09–2.01).